Determination of Glycemic Index (GI) of Ten Food Products
NCT ID: NCT01679704
Last Updated: 2014-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2012-02-29
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glucose and Insulin Responses to Test Foods
NCT01671878
Glycemic Index of Various Types of Pasta in Healthy Volunteers
NCT04494607
Personalized Glucose Optimization Through Nutritional Intervention
NCT03708419
Glycemic Response Testing
NCT01536860
Effect of High and Low Glycemic Index Foods on Post Meal Pulse and Blood Pressure
NCT04910828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Food products
Ten food products will be given to all subjects
Food products
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Food products
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 21 to 60 years
Exclusion Criteria
* Suffering from gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism and excretion.
* History of diabtes mellitus or use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
* History of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
* Current use of medication that may interfere with the digestion and nutrient absorption (for examples steriods, protease inhibitors or antipsychotics medications).
* Current use of medication known to affect glucose tolerance (excluding oral contraceptives).
* Known food allergy or intolerance.
21 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danone Asia Pacific Holdings Pte, Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kalpana Bhaskaran, Dr
Role: PRINCIPAL_INVESTIGATOR
Temasek Polytechnic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Temasek Polytechnic
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIS.2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.